Brad Dahms | Chief Financial Officer |
Carsten Brunn | President and Chief Executive Officer |
Peter Traber | Chief Medical Officer |
Takashi Kishimoto | Chief Scientific Officer |
Kristen Kluska | Cantor Fitzgerald |
Raju Prasad | William Blair |
John Newman | Canaccord |
Difei Yang | Mizuho Securities |
Chad Messer | Needham & Company |
Boobalan Pachaiyappan | H.C. Wainwright |
Ben Porter | Stifel |
Good morning, and welcome to the Selecta Biosciences First Quarter 2021 Financial Results and Corporate Update Conference Call. Currently, all participants are in a listen-only mode. [Operator Instructions] This call is being webcast live on the Investors & Media section of Selecta's website at www.selectabio.com and it is being recorded.
For opening remarks, I would like to introduce, Brad Dahms, Chief Financial Officer of Selecta. Please go ahead.